(Q43873749)

27 November 2017

title

A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine (English)

1 reference

27 November 2017

1 reference

Linda L Carpenter

1

1 reference

27 November 2017

Sarah Yasmin

series ordinal

2

1 reference

27 November 2017

Lawrence H Price

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

published in

Biological Psychiatry

1 reference

27 November 2017

volume

51

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

183-188

1 reference

Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901262-8

Mirtazapine augmentation in the treatment of refractory depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901262-8

The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901262-8

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901262-8

Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901262-8

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901262-8

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901262-8

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901262-8

Are two antidepressant mechanisms better than one?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901262-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(01)01262-8

1 reference

27 November 2017

1 reference